JP2017526644A5 - - Google Patents

Download PDF

Info

Publication number
JP2017526644A5
JP2017526644A5 JP2017501706A JP2017501706A JP2017526644A5 JP 2017526644 A5 JP2017526644 A5 JP 2017526644A5 JP 2017501706 A JP2017501706 A JP 2017501706A JP 2017501706 A JP2017501706 A JP 2017501706A JP 2017526644 A5 JP2017526644 A5 JP 2017526644A5
Authority
JP
Japan
Prior art keywords
independently
hours
epha4
seq
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017501706A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017526644A (ja
JP6847824B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/040649 external-priority patent/WO2016011201A2/en
Publication of JP2017526644A publication Critical patent/JP2017526644A/ja
Publication of JP2017526644A5 publication Critical patent/JP2017526644A5/ja
Application granted granted Critical
Publication of JP6847824B2 publication Critical patent/JP6847824B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017501706A 2014-07-15 2015-07-15 神経保護および神経修復用のｅｐｈａ４環状ペプチドアンタゴニスト Active JP6847824B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462025002P 2014-07-15 2014-07-15
US62/025,002 2014-07-15
PCT/US2015/040649 WO2016011201A2 (en) 2014-07-15 2015-07-15 Epha4 cyclic peptide antagonists for neuroprotection and neural repair

Publications (3)

Publication Number Publication Date
JP2017526644A JP2017526644A (ja) 2017-09-14
JP2017526644A5 true JP2017526644A5 (https=) 2018-09-20
JP6847824B2 JP6847824B2 (ja) 2021-03-31

Family

ID=55079168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017501706A Active JP6847824B2 (ja) 2014-07-15 2015-07-15 神経保護および神経修復用のｅｐｈａ４環状ペプチドアンタゴニスト

Country Status (4)

Country Link
US (1) US10322161B2 (https=)
EP (1) EP3169344B1 (https=)
JP (1) JP6847824B2 (https=)
WO (1) WO2016011201A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017011812A1 (en) * 2015-07-15 2017-01-19 Sanford Burnham Prebys Medical Discovery Institute Modified epha4 cyclic peptide antagonists for neuroprotection and neural repair
WO2019213620A1 (en) * 2018-05-04 2019-11-07 Iron Horse Therapeutics, Inc. Epha4 cyclic peptide antagonists and methods of use thereof
AU2020288188A1 (en) 2019-06-07 2022-01-27 Anders, Sonnerborg, Peptide inhibitors for the inhibition of hiv capsid
WO2024233346A1 (en) * 2023-05-05 2024-11-14 Sanford Burnham Prebys Medical Discovery Institute Epha4 antagonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004028551A1 (en) * 2002-09-24 2004-04-08 The Burnham Institute Novel agents that modulate eph receptor activity
WO2006026820A1 (en) 2004-09-08 2006-03-16 The University Of Queensland Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor

Similar Documents

Publication Publication Date Title
JP5801197B2 (ja) 痛みの治療に関する薬剤及び方法
KR20240025721A (ko) 노화와 연관된 질환을 치료하기 위한 방법 및 조성물
JP5345929B2 (ja) 環状アルファ−コノトキシンペプチド
WO2015197193A2 (en) New use for jnk inhibitor molecules for treatment of various diseases
EP3169344B1 (en) Epha4 cyclic peptide antagonists for neuroprotection and neural repair
JP2017526644A5 (https=)
JP4402455B2 (ja) 細胞の分化、増殖、再生、可塑性及び生存に影響を及ぼすことができる化合物
US20180170983A1 (en) New Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Mild Cognitive Impairment
Granic et al. LPYFDa neutralizes amyloid-β-induced memory impairment and toxicity
WO2021200259A1 (ja) Ｖｉｐｒ２アンタゴニストペプチド
WO2017011812A1 (en) Modified epha4 cyclic peptide antagonists for neuroprotection and neural repair
CA3225100A1 (en) Inhibitors and uses thereof
PT1765851E (pt) Compostos análogos de péptidos analgésicos derivados do veneno de serpentes crotalus durissus terrificus, suas utilizações, composições, métodos de preparação e purificação
KR20220041764A (ko) 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체 또는 이의 결합체의 신경퇴행성 질환의 치료 용도
KR101131512B1 (ko) 퇴행성신경질환 예방 또는 치료용 약제학적 조성물
CN112194730A (zh) 一种多肽ti-16及其用途
WO2021091871A1 (en) High affinity and dual-specificity peptide antagonists of mdm2 and mdmx for p53 activation
US20230374067A1 (en) Novel peptoids and use thereof for preventing or treating chronic pain
US20210238229A1 (en) Peptide for disease treatment
KR20250166123A (ko) 신경계 복구를 위한 단백질 티로신 포스파타제 웨지 도메인 펩티드 이량체
AU2024314499A1 (en) Modified polypeptide and use thereof in field of analgesia
CN117881687A (zh) 多肽抑制剂及其用途
KR20230076560A (ko) 아밀로이드 전구체 단백질에 대한 저해 활성을 갖는 펩타이드 및 이의 용도
CA3182939A1 (en) Jnk3 inhibitory peptides
WO2016090495A1 (en) TARGETED α-L-IDURONIDASE CONJUGATES AND USES THEREOF